Janus Henderson Group’s Tourmaline Bio TRML Stock Holding History

Janus Henderson Group’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,926	Closed	-$283K	–	2470
2025 Q3	$283K	Buy	+5,926	New	+$164K	﹤0.01%	2231
2024 Q3	–	Sell	-11,500	Closed	-$148K	–	2557
2024 Q2	$148K	Sell	11,500 -93	-0.8%	-$1.5K	﹤0.01%	2462
2024 Q1	$266K	Buy	+11,593	New	+$409K	﹤0.01%	2286

Janus Henderson Group's TRML Position: Q4 2025 in Review

Janus Henderson Group sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 5,926 shares — an estimated $283K sold.

Janus Henderson Group first reported a position in TRML in Q1 2024 and held it in 3 quarters. The position peaked at $283K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Janus Henderson Group reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Janus Henderson Group sold 5,926 Tourmaline Bio shares in Q4 2025, an estimated $283K.
Janus Henderson Group first reported a position in Tourmaline Bio in Q1 2024 and held it in 3 quarters.
Janus Henderson Group's Tourmaline Bio position peaked at $283K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Janus Henderson Group's 13F filing for Q4 2025, filed 17 Feb 2026.